C-Peptide, Eight Specimens
Use
The C-Peptide, Eight Specimens test is typically used to assess and monitor beta cell function in patients by measuring the level of C-peptide in the blood. C-peptide is released when insulin is produced, thus serving as a marker for the body's own insulin production. This test can help physicians determine the amount of insulin a patient's pancreas is producing, during various time points. It is particularly valuable for differentiating between insulin produced by the body and insulin from injected medication, thus useful for managing insulinomas, hypoglycemia, and diabetes treatment.
Special Instructions
This panel is a series panel requiring multiple tubes to be drawn at multiple time points. It involves initial blood collection followed by administration of a drug or treatment like glucola and subsequent collections. Ensure to stop biotin consumption at least 72 hours before sample collection to avoid interference.
Limitations
This test may exhibit interference from patients consuming high doses of biotin (vitamin B7/B8, vitamin H, coenzyme R), which should be stopped 72 hours prior to testing. Additionally, not collecting the series at correct times or not contacting the clinician before collecting it might affect the results. C-Peptide reference interval is established for fasting patients, and results may vary based on the time and nature of the intervention and patient condition.
Methodology
Automated Analyzer (Clinical Chemistry)
Biomarkers
LOINC Codes
- 57376-6
- 57376-6
- 13032-8
- 13033-6
- 13034-4
- 13035-1
- 13036-9
- 16501-9
- 16502-7
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Container
Multiple tubes
Collection Instructions
Collect an initial tube (baseline) then administer a drug or other treatment, and collect additional tubes after the dose. Ensure biotin supplementation has been ceased 72 hours prior to collection.
Patient Preparation
Patients should stop biotin consumption at least 72 hours before the sample collection.